HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R R Weichselbaum Selected Research
R R Weichselbaum Research Topics
Disease
19
Neoplasms (Cancer)
01/2017 - 01/2000
4
Prostatic Neoplasms (Prostate Cancer)
06/2009 - 01/2001
4
Infections
11/2001 - 01/2000
3
Head and Neck Neoplasms (Head and Neck Cancer)
03/2013 - 04/2000
2
Melanoma (Melanoma, Malignant)
07/2015 - 04/2009
2
Glioma (Gliomas)
11/2011 - 10/2001
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2001 - 02/2000
1
Urinary Bladder Neoplasms (Bladder Cancer)
10/2016
1
Lymphoma (Lymphomas)
05/2015
1
Hematologic Neoplasms (Hematological Malignancy)
05/2015
1
Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2003
1
Herpes Simplex
09/2002
1
Hyperplasia
12/2001
1
Adenocarcinoma
10/2001
1
Carcinogenesis
10/2001
1
Oropharyngeal Neoplasms
03/2001
1
Laryngeal Neoplasms (Laryngeal Cancer)
03/2001
1
Lewis Lung Carcinoma
09/2000
1
Virus Diseases (Viral Diseases)
09/2000
1
Breast Neoplasms (Breast Cancer)
08/2000
1
Wounds and Injuries (Trauma)
08/2000
1
Paresis (Hemiparesis)
08/2000
1
Hypocalcemia
08/2000
1
B-Cell Lymphoma (Lymphoma, B Cell)
04/2000
1
Squamous Cell Carcinoma of Head and Neck
02/2000
1
Glioblastoma (Glioblastoma Multiforme)
01/2000
Drug/Important Bio-Agent (IBA)
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2009 - 06/2001
4
Proteins (Proteins, Gene)
FDA Link
01/2006 - 01/2000
3
DNA (Deoxyribonucleic Acid)
IBA
09/2002 - 08/2000
2
Biological Products
IBA
03/2013 - 06/2001
2
Cyclin A
IBA
11/2001 - 01/2000
1
Antigens
IBA
01/2017
1
Interferon Type I
IBA
01/2017
1
Biomarkers (Surrogate Marker)
IBA
10/2016
1
Small Interfering RNA (siRNA)
IBA
07/2015
1
Messenger RNA (mRNA)
IBA
05/2015
1
Alkylating Agents
IBA
05/2015
1
adenovirus receptor
IBA
03/2013
1
Luciferases
IBA
11/2011
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
04/2009
1
Type I Tumor Necrosis Factor Receptors
IBA
04/2009
1
Prostate-Specific Antigen (Semenogelase)
IBA
12/2001
1
Phenobarbital (Luminal)
FDA Link
12/2001
1
Phosphotransferases (Kinase)
IBA
11/2001
1
Pemetrexed (MTA)
FDA Link
10/2001
1
Prodrugs
IBA
10/2001
1
Connexin 43 (Connexin43)
IBA
10/2001
1
Connexins
IBA
10/2001
1
benzyloxycarbonylleucyl-leucyl-leucine aldehyde
IBA
09/2001
1
Protein Isoforms (Isoforms)
IBA
09/2001
1
Cyclin D3
IBA
09/2000
1
Viral Proteins
IBA
09/2000
1
Endostatins
IBA
09/2000
1
Cisplatin (Platino)
FDA Link
Generic
08/2000
1
Angiostatins
IBA
05/2000
1
Ceramides
IBA
04/2000
1
Sphingomyelin Phosphodiesterase (Sphingomyelinase)
IBA
04/2000
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
04/2000
1
Protein Kinase C
IBA
02/2000
1
Antineoplastic Agents (Antineoplastics)
IBA
02/2000
1
chelerythrine
IBA
02/2000
Therapy/Procedure
9
Radiotherapy
01/2017 - 05/2000
8
Therapeutics
01/2017 - 01/2000
6
Chemoradiotherapy
03/2013 - 04/2000
3
Drug Therapy (Chemotherapy)
01/2017 - 03/2008
3
Induction Chemotherapy
04/2003 - 03/2001
2
Aftercare (After-Treatment)
03/2013 - 02/2000
2
Conformal Radiotherapy
01/2002 - 01/2001
2
Adjuvant Radiotherapy
03/2001 - 03/2001
1
Immunotherapy
01/2017
1
Re-Irradiation
03/2013
1
Injections
12/2000
1
Tracheotomy
08/2000
1
Neck Dissection (Radical Neck Dissection)
08/2000